Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
RECRUITING
Total Enrollment
360 participants
Study Classification
OBSERVATIONAL
Study Start Date
2023-04-05
Study Completion Date
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The SKyRoCKeT Study (Surface-Knit and Reformulate CADENCE-Kids for Translation) will recruit a sex- and age-balanced sample of 360 young people 6-20 years of age to develop an integrative, physiologically-coherent age-cadence-log(metabolic equivalent, MET) surface-based model, reformulate the prior R21 CADENCE-Kids study (1; NCT01989104) by providing individualized, more precise, age-specific and coherent cadence-intensity thresholds, investigate additional differences by anthropometric factors, and translate cadence-intensity thresholds to over-ground walking. The SKyRoCKeT Study is an innovative critical step to provide a coherent, interpretable, objectively monitored step-based intensity metric to inform (inter)national physical activity (PA) guidelines by transforming currently vague guidelines of PA intensity into quantifiable PA recommendations that can be of widespread use, which clinicians, young people, parents, and researchers can integrate into preventive care management and action plans for personalized care. The SKyRoCKeT Study will allow for a user-friendly, interpretable metric to more accurately inform public health/behavioral interventions, assessments, analyses, school-based health and physical education curricula and programs, and public health messages for young people and their caregivers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Motility Mother-Child Cohort
NCT05491161
Diet, Healthy
Infant Development
ACTIVE_NOT_RECRUITING
High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
NCT01656590
Glycogen Storage Disease Type II
WITHDRAWN
PHASE2
Exploring Food Rejection Dispositions as Potential Risk Factors for Undernutrition in Hospitalized Children Aged 2 to 8
NCT06330025
Undernutrition
COMPLETED
Pediatric Gastroparesis Registry
NCT03680820
Gastroparesis
Gastroparesis-like Syndrome
COMPLETED
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
NCT00728104
Cyclic Vomiting Syndrome
WITHDRAWN
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Aims: The SKyRoCKeT Study will:
1. Expand CADENCE-Kids (1; NCT01989104) to innovatively surface-'knit' the age dimension through a continuous, unbiased-by-age, and physiologically-coherent age-cadence-log(MET) flexible surface approach without artificially-generated jumps between age ranges and with enhanced precision of cadence-intensity threshold estimates. This single surface will coherently transition between ages, borrow inter-age information, and be data-driven.
2. Reformulate CADENCE-Kids (1; NCT01989104) by providing age-specific cadence-intensity thresholds, calculated with enhanced precision for moderate and vigorous PA. Data will be objectively collected using a similar treadmill protocol to the R21-funded pilot study, with incrementally faster paces. Age-specific results will be compared to the pilot's age-range thresholds. A full running bout will now also be included. The investigators will concurrently collect cadence with direct observation and with multiple contemporary wearable technologies. Collecting cardiorespiratory fitness (CRF) and habitual PA data, the investigators will develop additional, innovative algorithms to predict relative intensity defined by lab-based indicators of oxygen uptake (%VO2peak, %VO2R), heart rate (%HRR, %HRmax), and rate of perceived of exertion (RPE) to facilitate computation of individually calibrated thresholds applicable to the free-living or habitual PA living condition. Investigators will assess differences in surfaces and cadence-intensity thresholds by sex and body mass index standard deviation scores (BMI SDS). Height- and/or leg-length-specific (hyper)surfaces will be explored as more precise alternatives to age.
3. Propel science forward innovatively through translation to over-ground walking. The investigators hypothesize that treadmill-set cadence-intensity thresholds will reliably translate and be useful for eliciting predictable metabolic costs during over-ground walking emblematic of free-living ambulatory behaviors.
Protocol/Procedures: 3 visits to the lab and 1 at home, free-living protocol
Screening: Screening questions will be completed online by potential participants (or their parents, where appropriate) and will take approximately 5 minutes. Following the initial recruitment web screener, potential participants (or their parents, where appropriate) will complete a telephone screener to confirm their responses. Potential participants (or their parents, where appropriate) will then attend a virtual or in-person orientation during which the study design procedures will be described in detail. Eligible potential participants who remain interested in the study will be scheduled for their first lab visit (with their parent/guardian if between 6-17 years of age).
Days of Testing in the Lab: Upon signing informed consent(s), participants must be fasted (no food for 4 hours before visit). Study procedures involving participants will be completed at the University of North Carolina at Charlotte. Visits 1 and 2 will be conducted at the Health Risk Assessment Laboratory (HRAL), and visit 3 will be conducted on an indoor track. Visit 1 will occur first and will be immediately followed by a week of free-living physical activity monitoring at home. Visit 2 will be completed once free-living, at-home monitoring is complete, and will be followed by visit 3.
Visit 1
* Demographic characteristic questions (approximately 5 minutes):
o Participants will self-report their sex, race/ethnicity, and date of birth. Date of birth will be confirmed using a government issued ID (e.g. passport, driver's license or birth certificate).
* Anthropometrics (approximately 10 minutes):
* Standing and seated height will be measured using a stadiometer.
* Weight, BMI, and body fat percentage will be measured using a specialized scale; both weight with and without wearable devices will be measured.
* Instrument attachment, treadmill walking, free-living activities (approximately 140 minutes)
* Participants will be fitted with multiple wearable devices (e.g., Fitbit, Apple Watch) to measure/monitor physical activity throughout the testing session.
* Participants will then complete several low intensity free-living activities while their physical activity and oxygen uptake are concurrently measured. Specifically, participants will rest in a chair, watch a portion of a child-friendly movie while seated, and color in a coloring book while seated in a chair. Each activity will last for 5 minutes, and a 2-minute rest will occur between each activity
* Participants will then begin the submaximal test by completing a series of walking bouts on a treadmill while their physical activity and oxygen uptake are concurrently measured. The walking bouts start at 0.5 miles per hour at a 0% incline and end at 6 miles per hour (0.5 miles per hour increments). A 2-minute rest will occur between each treadmill bout.
* Following a 5-minute break, participants will then complete three additional free-living activities where physical activity and oxygen uptake continue to be concurrently measured. Specifically, participants will step up and down on an aerobic step at 88 beats per minute, dribble a basketball, and perform jumping jacks at 126 beats per minute (63 jumping jacks per minute). Each activity will last for 5 minutes and a 2-minute rest will occur between each activity.
Free-Living, At-Home Monitoring
* Each participant's free-living physical activity will be monitored for 7 whole consecutive days using an ActiGraph GT9X accelerometer positioned on the waist. Participants will wear the accelerometer for 24 hours a day and be asked to maintain their usual lifestyle.
* Participants will complete a physical activity monitoring log, where they will indicate bedtimes, waketimes, and times when the monitor is removed for bathing, swimming, etc.
Visit 2
* Upon returning their free-living wearable monitor and physical activity log, participants will wear a Polar H10 Heart Rate Monitor and a K5 Portable Metabolic Unit during the second visit.
* Cardiorespiratory fitness will be measured by a VO2Peak test, conducted on a treadmill. Participants will walk at a moderate speed, between 2.5 and 3.5 mph. Data collection will begin following completion of a 3-minute warm-up at 0% incline. During the first minute of this warm up, the participant will walk at 1.5 mph. There will be a 1-minute transition period where the treadmill speed will increase to a fast walking speed (2.5-3.5 mph), and another minute will be spent at this speed. The speed determined at the transition period will stay the same for the duration of the test. The treadmill incline will then increase from a 0% incline to a 2% incline. The incline will increase by 2% every two minutes for the first 2 intervals, and then by 1% every minute thereafter.
* Although highly unlikely, if someone continues past the 18% grade, the speed will be increased by 0.2 mph every minute until the test is terminated.
* Rate of perceived exertion will be measured during the last 15 seconds of each testing bout. Gas exchange and heart rate will be monitored continuously.
Visit 3
* Short distance walk
* Participants will perform a series of self-paced (normal, slow, fast) walks over an electronic, pressure sensitive walkway.
* Cadence will be determined using data from the pressure sensitive walkway and will inform the speeds used in the following overground walk protocol.
* Overground walk
* Participants will be fitted with multiple wearable devices (e.g., Fitbit, Apple Watch) to measure/monitor physical activity throughout the testing session.
* Participants will also wear headphones and be instructed to match their step timing to the tempo they hear in the headphones.
* After conducting a practice lap, participants will perform five 5-minute overground walks around two, 84 foot by 50 foot basketball courts, each at a different walking speed and to a different tempo played through the headphones. The first three will be at a tempo corresponding to the self-selected slow, normal, and fast walking cadences determined during the short distance walk, respectively. The fourth and fifth tempos will correspond to moderate and vigorous intensity physical activity cadences identified from our previous CADENCE-Kids pilot study (1; NCT01989104). Participants unable to match their steps to the tempo during the practice lap will perform additional laps with the guidance of a pacer. The pacer will walk directly behind participants and support the step timing by verbalizing 'LEFT/RIGHT' at the appropriate timing.
* Participants will walk over the pressure sensitive walkway every time they complete a lap around the courts, and may walk over the pressure sensitive walkway more than once during each of the 5 bouts.
* A lab member will manually count total steps for each bout via hand tally. Video recording of participants' lower body movements will be taken to provide redundant step-counting. Digital data displayed on the screens of the wearable devices will be reported at the end of each bout, and data from these wearables will be downloaded after data collection is complete.
1. Expand CADENCE-Kids (1; NCT01989104) to innovatively surface-'knit' the age dimension through a continuous, unbiased-by-age, and physiologically-coherent age-cadence-log(MET) flexible surface approach without artificially-generated jumps between age ranges and with enhanced precision of cadence-intensity threshold estimates. This single surface will coherently transition between ages, borrow inter-age information, and be data-driven.
2. Reformulate CADENCE-Kids (1; NCT01989104) by providing age-specific cadence-intensity thresholds, calculated with enhanced precision for moderate and vigorous PA. Data will be objectively collected using a similar treadmill protocol to the R21-funded pilot study, with incrementally faster paces. Age-specific results will be compared to the pilot's age-range thresholds. A full running bout will now also be included. The investigators will concurrently collect cadence with direct observation and with multiple contemporary wearable technologies. Collecting cardiorespiratory fitness (CRF) and habitual PA data, the investigators will develop additional, innovative algorithms to predict relative intensity defined by lab-based indicators of oxygen uptake (%VO2peak, %VO2R), heart rate (%HRR, %HRmax), and rate of perceived of exertion (RPE) to facilitate computation of individually calibrated thresholds applicable to the free-living or habitual PA living condition. Investigators will assess differences in surfaces and cadence-intensity thresholds by sex and body mass index standard deviation scores (BMI SDS). Height- and/or leg-length-specific (hyper)surfaces will be explored as more precise alternatives to age.
3. Propel science forward innovatively through translation to over-ground walking. The investigators hypothesize that treadmill-set cadence-intensity thresholds will reliably translate and be useful for eliciting predictable metabolic costs during over-ground walking emblematic of free-living ambulatory behaviors.
Protocol/Procedures: 3 visits to the lab and 1 at home, free-living protocol
Screening: Screening questions will be completed online by potential participants (or their parents, where appropriate) and will take approximately 5 minutes. Following the initial recruitment web screener, potential participants (or their parents, where appropriate) will complete a telephone screener to confirm their responses. Potential participants (or their parents, where appropriate) will then attend a virtual or in-person orientation during which the study design procedures will be described in detail. Eligible potential participants who remain interested in the study will be scheduled for their first lab visit (with their parent/guardian if between 6-17 years of age).
Days of Testing in the Lab: Upon signing informed consent(s), participants must be fasted (no food for 4 hours before visit). Study procedures involving participants will be completed at the University of North Carolina at Charlotte. Visits 1 and 2 will be conducted at the Health Risk Assessment Laboratory (HRAL), and visit 3 will be conducted on an indoor track. Visit 1 will occur first and will be immediately followed by a week of free-living physical activity monitoring at home. Visit 2 will be completed once free-living, at-home monitoring is complete, and will be followed by visit 3.
Visit 1
* Demographic characteristic questions (approximately 5 minutes):
o Participants will self-report their sex, race/ethnicity, and date of birth. Date of birth will be confirmed using a government issued ID (e.g. passport, driver's license or birth certificate).
* Anthropometrics (approximately 10 minutes):
* Standing and seated height will be measured using a stadiometer.
* Weight, BMI, and body fat percentage will be measured using a specialized scale; both weight with and without wearable devices will be measured.
* Instrument attachment, treadmill walking, free-living activities (approximately 140 minutes)
* Participants will be fitted with multiple wearable devices (e.g., Fitbit, Apple Watch) to measure/monitor physical activity throughout the testing session.
* Participants will then complete several low intensity free-living activities while their physical activity and oxygen uptake are concurrently measured. Specifically, participants will rest in a chair, watch a portion of a child-friendly movie while seated, and color in a coloring book while seated in a chair. Each activity will last for 5 minutes, and a 2-minute rest will occur between each activity
* Participants will then begin the submaximal test by completing a series of walking bouts on a treadmill while their physical activity and oxygen uptake are concurrently measured. The walking bouts start at 0.5 miles per hour at a 0% incline and end at 6 miles per hour (0.5 miles per hour increments). A 2-minute rest will occur between each treadmill bout.
* Following a 5-minute break, participants will then complete three additional free-living activities where physical activity and oxygen uptake continue to be concurrently measured. Specifically, participants will step up and down on an aerobic step at 88 beats per minute, dribble a basketball, and perform jumping jacks at 126 beats per minute (63 jumping jacks per minute). Each activity will last for 5 minutes and a 2-minute rest will occur between each activity.
Free-Living, At-Home Monitoring
* Each participant's free-living physical activity will be monitored for 7 whole consecutive days using an ActiGraph GT9X accelerometer positioned on the waist. Participants will wear the accelerometer for 24 hours a day and be asked to maintain their usual lifestyle.
* Participants will complete a physical activity monitoring log, where they will indicate bedtimes, waketimes, and times when the monitor is removed for bathing, swimming, etc.
Visit 2
* Upon returning their free-living wearable monitor and physical activity log, participants will wear a Polar H10 Heart Rate Monitor and a K5 Portable Metabolic Unit during the second visit.
* Cardiorespiratory fitness will be measured by a VO2Peak test, conducted on a treadmill. Participants will walk at a moderate speed, between 2.5 and 3.5 mph. Data collection will begin following completion of a 3-minute warm-up at 0% incline. During the first minute of this warm up, the participant will walk at 1.5 mph. There will be a 1-minute transition period where the treadmill speed will increase to a fast walking speed (2.5-3.5 mph), and another minute will be spent at this speed. The speed determined at the transition period will stay the same for the duration of the test. The treadmill incline will then increase from a 0% incline to a 2% incline. The incline will increase by 2% every two minutes for the first 2 intervals, and then by 1% every minute thereafter.
* Although highly unlikely, if someone continues past the 18% grade, the speed will be increased by 0.2 mph every minute until the test is terminated.
* Rate of perceived exertion will be measured during the last 15 seconds of each testing bout. Gas exchange and heart rate will be monitored continuously.
Visit 3
* Short distance walk
* Participants will perform a series of self-paced (normal, slow, fast) walks over an electronic, pressure sensitive walkway.
* Cadence will be determined using data from the pressure sensitive walkway and will inform the speeds used in the following overground walk protocol.
* Overground walk
* Participants will be fitted with multiple wearable devices (e.g., Fitbit, Apple Watch) to measure/monitor physical activity throughout the testing session.
* Participants will also wear headphones and be instructed to match their step timing to the tempo they hear in the headphones.
* After conducting a practice lap, participants will perform five 5-minute overground walks around two, 84 foot by 50 foot basketball courts, each at a different walking speed and to a different tempo played through the headphones. The first three will be at a tempo corresponding to the self-selected slow, normal, and fast walking cadences determined during the short distance walk, respectively. The fourth and fifth tempos will correspond to moderate and vigorous intensity physical activity cadences identified from our previous CADENCE-Kids pilot study (1; NCT01989104). Participants unable to match their steps to the tempo during the practice lap will perform additional laps with the guidance of a pacer. The pacer will walk directly behind participants and support the step timing by verbalizing 'LEFT/RIGHT' at the appropriate timing.
* Participants will walk over the pressure sensitive walkway every time they complete a lap around the courts, and may walk over the pressure sensitive walkway more than once during each of the 5 bouts.
* A lab member will manually count total steps for each bout via hand tally. Video recording of participants' lower body movements will be taken to provide redundant step-counting. Digital data displayed on the screens of the wearable devices will be reported at the end of each bout, and data from these wearables will be downloaded after data collection is complete.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Healthy
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
6-20-year-old youth
6-20-year-old youth
N/A: SKyRoCKeT is an observational study
Intervention Type
OTHER
None; this is an observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N/A: SKyRoCKeT is an observational study
None; this is an observational study
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 6 - 20 years of age on the day of signing the informed consent/assent.
* Able to walk without the need of assistance
* Able to walk without the need of assistance
Exclusion Criteria
* Need for assistance with walking including the use of a wheelchair
* Mental illness requiring hospitalization within the past 5 years
* Medical condition or medications that affect(s) changes in heart rate with exercise
* Current pregnancy
* Pacemaker or other implanted medical device including metal joint replacements
* History of cardiovascular disease, stroke, transient ischemic attacks (TIA, mini-stroke), chest pain, unusual shortness of breath during physical activity/exercise, swelling in legs/ankles, or excessive leg pain with exercise.
* History of musculoskeletal problems that cause pain during physical activity which interferes with the ability to walk
* Exercise-induced asthma requiring medications prior to low intensity activities like walking
* Unavailable for the entire duration of the study period
* Mental illness requiring hospitalization within the past 5 years
* Medical condition or medications that affect(s) changes in heart rate with exercise
* Current pregnancy
* Pacemaker or other implanted medical device including metal joint replacements
* History of cardiovascular disease, stroke, transient ischemic attacks (TIA, mini-stroke), chest pain, unusual shortness of breath during physical activity/exercise, swelling in legs/ankles, or excessive leg pain with exercise.
* History of musculoskeletal problems that cause pain during physical activity which interferes with the ability to walk
* Exercise-induced asthma requiring medications prior to low intensity activities like walking
* Unavailable for the entire duration of the study period
Minimum Eligible Age
6 Years
Maximum Eligible Age
20 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Sponsor Role
collaborator
University of North Carolina, Charlotte
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura H Gunn
Principal Investigator
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catrine Tudor-Locke, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina at Charlotte
Laura H Gunn, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina at Charlotte
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina at Charlotte
Charlotte, North Carolina, United States
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
United States
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Tudor-Locke C, Schuna JM Jr, Han H, Aguiar EJ, Larrivee S, Hsia DS, Ducharme SW, Barreira TV, Johnson WD. Cadence (steps/min) and intensity during ambulation in 6-20 year olds: the CADENCE-kids study. Int J Behav Nutr Phys Act. 2018 Feb 26;15(1):20. doi: 10.1186/s12966-018-0651-y.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-1200
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRBIS-21-0460
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Recurrent Abdominal Pain in Children
NCT00526903
COMPLETED
PHASE2
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
NCT00677508
COMPLETED
Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
NCT04279314
COMPLETED
PHASE3
Metabolic Evaluation of Nutrition in Rett Syndrome
NCT00786071
COMPLETED
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
NCT04629014
RECRUITING
Use of Prokinetics in Early Enteral Feeding in Preterm Infants
NCT01569633
WITHDRAWN
NA
Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children
NCT05609591
COMPLETED
NA
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
NCT02559570
COMPLETED
PHASE2
Nutritional Aspects of Rett Syndrome
NCT00004656
COMPLETED
NA
Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation
NCT03981510
UNKNOWN
NA
Follow-up of Adult Phenylketonuria (PKU) Patients
NCT01096758
COMPLETED
Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
NCT06380387
RECRUITING
NA
MSOT and MRI for Non-invasive Assessment of Intestinal Transit Time in Children With Chronic Bowel Emptying Disorders
NCT06911749
RECRUITING
NA
Methionine Metabolism in Enterally Fed Pediatric Sepsis
NCT01889264
COMPLETED
An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children
NCT02985567
COMPLETED
Trial of Cocoa-based Food in Children
NCT01358149
COMPLETED
NA
The Treatment of Recurrent Abdominal Pain in Children
NCT00852878
WITHDRAWN
NA
Oral Exploration of Objects and Food Diversification
NCT05157633
COMPLETED
Changes in Nerve Electro Physiologic Properties in Children Before and After Correction of Malnutrition
NCT05891457
COMPLETED
NA
Chromium Contamination of Parenteral Nutrition
NCT03906890
COMPLETED
Fiber Tolerability in Children
NCT02519374
COMPLETED
NA
New Mechanisms of Obesity
NCT06768827
RECRUITING
NA
Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome
NCT06856759
RECRUITING
EARLY_PHASE1
Choline Nutrition in Children With Cystic Fibrosis (CF)
NCT00686361
COMPLETED
NA
Creatine Metabolism in Rett Syndrome
NCT01198015
COMPLETED